During the past decade, Lubbock Heart Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lubbock Heart Hospital" #1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Lubbock Heart Hospital" are "Coronary Artery Disease" (2 trials), "Coronary Disease" (2 trials), "Coronary Restenosis" (2 trials), "Chronic Total Occlusion of Coronary Artery" (1 trials) and "Coronary Artery Stenosis" (1 trials). Many other conditions were trialed in "Lubbock Heart Hospital" in a lesser frequency.

Most popular intervention types in "Lubbock Heart Hospital" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent" (1 trials), "XIENCE V Everolimus Eluting Coronary Stent System (XIENCE V EECSS)" (1 trials), "ZoMaxx™ Drug-Eluting Coronary Stent System" (1 trials), "clopidogrel + aspirin OR prasugrel + aspirin" (1 trials) and "placebo + aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lubbock Heart Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lubbock Heart Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lubbock Heart Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lubbock Heart Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".